Global Alopecia Treatment Market, accounted for US$ 7,325.0 million in 2017, and is expected to witness a CAGR of 4.9% over the forecast period (2018–2026).
Major market players are focusing on product approvals and launches for developing novel products for addressing critical unmet requirements of patients. For instance, Aclaris Therapeutics, Inc., in July 2018, received the grant from the U.S. Food and Drug Administration (FDA) as the Fast Track designation for investigational topical Janus Kinase (JAK) 1/3 inhibitor (ATI-502) by Aclaris to treat alopecia areata, such as patchy alopecia areata and the disease’s variants, universalis and alopecia totalis.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1847
Furthermore, strong pipeline is expected to launch modern alopecia drugs, which is expected to boost growth of the global alopecia treatment market over the forecast period. For instance, the Spain-based company -Almirall, in June 2018, published the Phase III trial’s results of ALM12845/P-3074 for the androgenic alopecia. Company aimed for the drug’s regulatory filing within the E.U. till 2019’s end.
Furthermore, rising radiation therapy and chemotherapy use to treat cancer, causes alopecia, which is expected to fuel growth of the global alopecia treatment market over the forecast period. As per the National Center for Biotechnology Information (NCBI), published February 2017 study, alopecia incidence associated with categories of chemotherapy drug including topoisomerase inhibitors leads to over 60% – 100 % alopecia, anti-microtubule agents causes over 80% alopecia. Major market players are focusing on adopting strategies including acquisitions and mergers to enhance the product portfolios. For instance, Aclaris Therapeutics, Inc., in 2017, acquired a firm focused kinase inhibitors’ on development and discovery- Confluence Life Sciences, Inc., for treating autoimmune disorders including alopecia areata, atopic dermatitis, vitiligo, and others.
Global Alopecia Treatment Market: Key Takeaways
The global alopecia treatment market is expected to proliferate at a 4.9% CAGR over the forecast period, due to rising alopecia’s prevalence. In January 2019, as per the Orphanet Report, the Alopecia Universalis’ prevalence was over 25/100,000 and incidence of Alopecia Totalis was over 10.5/ 100,000 among the European populace.
Based on disease types, the segment of androgenic alopecia dominated the global alopecia treatment market in 2018, due to rising androgenic alopecia cases and rising in progress clinical trials. For instance, Assiut University, in March 2019, initiated clinical study to evaluate the efficiency and role of Vitamin D to treat androgenic alopecia. This trial is expected to be over by December 2019.
Based on drug types, the segment of topical agents dominated the global alopecia treatment market in 2018, due to rising drug candidates in the topical agents’ category. For instance, Energenesis Biomedical Co., Ltd., in May 2018, collaborated with A2 Healthcare Taiwan Corporation, to initiate clinical trial of phase 2 to evaluate ENERGI-F701 solution’s safety and efficacy for topical usage in pattern baldness in females. This study was finished in March 2019.
Major players functioning in the global alopecia treatment market are Histogen Inc., Aclaris Therapeutics, Inc., Cipla Limited, Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., and others
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1847
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Drug Type
- Market Snippet, By Gender
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Epidemiology
- Collaboration and Acquisitions
- New Product Launches
- Market Trends
- Regulatory Scenario
- Merger and Acquisition Scenario
- Key Highlights
- PEST Analysis
- Market Dynamics
- Global Alopecia Treatment Market, By Disease Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Androgenic Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Alopecia Areata
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Alopecia Treatment Market, By Drug Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Topical Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- 5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Alopecia Treatment Market, By Gender, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Alopecia Treatment Market , By Route of Administration, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Alopecia Treatment Market , By Distribution Channel, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Alopecia Treatment Market , By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Histogen Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aclaris Therapeutics, Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Concert Pharmaceuticals, Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Daiichi Sankyo Company, Limited
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Histogen Inc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837